𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hydroxyurea treatment of sickle cell anemia in hospital-based practices

✍ Scribed by Robert P. Ferguson; Anuradha Arun; Chris Carter; Stanley D. Walker; Oswaldo Castro

Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
47 KB
Volume
70
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cost-effectiveness of hydroxyurea in sic
Cost-effectiveness of hydroxyurea in sickle cell anemia
✍ Moore, Richard D.; Charache, Samuel; Terrin, Michael L.; Barton, Franca B.; Ball πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 38 KB πŸ‘ 2 views

The Multicenter Study of Hydroxyurea in Sickle Cell Anemia (MSH) demonstrated the efficacy of hydroxyurea in reducing the rate of painful crises compared to placebo. We used resource utilization data collected in the MSH to determine the cost-effectiveness of hydroxyurea. The MSH was a randomized, p

Hospitalization rates and costs of care
Hospitalization rates and costs of care of patients with sickle-cell anemia in the state of Maryland in the era of hydroxyurea
✍ Sophie Lanzkron; Carlton Haywood Jr; Jodi B. Segal; George J. Dover πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 1 views

## Abstract The multicenter study of hydroxyurea (MSH) in sickle‐cell anemia (SCA) demonstrated that patients treated with hydroxyurea (HU) had a 44% decrease in hospitalizations when compared with those taking placebo. A subsequent study looking at the cost‐effectiveness of HU showed that decrease

Rituximab as an effective treatment of h
Rituximab as an effective treatment of hyperhemolysis syndrome in sickle cell anemia
✍ Claude Bachmeyer; Jacqueline Maury; Antoine Parrot; Dora Bachir; Katia Stankovic πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 58 KB πŸ‘ 1 views

To the Editor: Erythrocytapheresis is an established therapy for the prevention of stroke in sickle cell disease [1]. We report its use in the prevention of recurrent acute coronary syndromes. A 50-year-old woman, with homozygous sickle cell disease presented in December 2005 with central chest pai